The Evolution of Systemic Microvascular Reactivity in Heart Transplant Patients
Recruiting
Observational Study
Heart Transplantation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 31 (estimated)
- Sponsor
- National Institute of Cardiology, Laranjeiras, Brazil · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The evolution of systemic microvascular reactivity may aid in the comprehension of cardiovascular physiology in heart transplantation patients, and possibly suggest the non-invasive evaluation of skin microcirculation as an ancillary tool in the clinical evaluation of these patients.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* capability to understand the objectives of the research and to fulfill the Term of Consent
Exclusion Criteria:
* Pregnancy, acute infection diagnosis, use of circulatory assistance devices
Contacts